Merck , known as MSD outside the United States and Canada, today announced that its New Drug Application for an investigational intravenous solution formulation of the company's antifungal agent, NOXAFILA , has been accepted for priority review by the U.S. Food and Drug Administration .
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20131118005336&newsLang=en&ndmConfigId=1000639&vnsId=41
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20131118005336&newsLang=en&ndmConfigId=1000639&vnsId=41
No comments:
Post a Comment